Federal Register / Vol. 86, No. 174 / Monday, September 13, 2021 / Notices 50907 

Controlled substance Drug code Schedule 

Ecgonine .......................................................................................................................................................................... 9180 II 

Ethylmorphine .................................................................................................................................................................. 9190 II 

Hydrocodone ................................................................................................................................................................... 9193 II 

Levomethorphan .............................................................................................................................................................. 9210 II 

Levorphanol ..................................................................................................................................................................... 9220 II 

Isomethadone .................................................................................................................................................................. 9226 II 

Meperidine ....................................................................................................................................................................... 9230 II 

Meperidine intermediate-B .............................................................................................................................................. 9233 II 

Oliriceridine ...................................................................................................................................................................... 9245 II 

Methadone ....................................................................................................................................................................... 9250 II 

Dextropropoxyphene, bulk (non-dosage forms) .............................................................................................................. 9273 II 

Morphine .......................................................................................................................................................................... 9300 II 

Thebaine .......................................................................................................................................................................... 9333 II 

Oxymorphone .................................................................................................................................................................. 9652 II 

Noroxymorphone ............................................................................................................................................................. 9668 II 

Thiafentanil ...................................................................................................................................................................... 9729 II 

Alfentanil .......................................................................................................................................................................... 9737 II 

Remifentanil ..................................................................................................................................................................... 9739 II 

Sufentanil ......................................................................................................................................................................... 9740 II 

Carfentanil ....................................................................................................................................................................... 9743 II 

Tapentadol ....................................................................................................................................................................... 9780 II 

Fentanyl ........................................................................................................................................................................... 9801 II 

The company plans to bulk 

manufacture the listed controlled 

substances for internal use or for sale to 

its customers. In reference to dug codes 

7360 (Marihuana), and 7370 

(Tetrahydrocannabinols), the company 

plans to bulk manufacture these drugs 

as synthetic. No other activities for these 

drug codes are authorized for this 

registration. 

Brian S. Besser, 

Acting Assistant Administrator. 

[FR Doc. 2021–19632 Filed 9–10–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Notice of Lodging of Proposed 

Consent Decree Under the 

Comprehensive Environmental 

Response, Compensation, and Liability 

Act 

On August 30, 2021, the Department 

of Justice lodged a proposed Consent 

Decree with the United States District 

Court for the Western District of 

Oklahoma in United States v. Land 

O’Lakes, Inc., et al., Civil Case No. 5:16– 

cv–00170 (W.D. Okla.). 

The United States filed this lawsuit 

under Section 107 of the 

Comprehensive Environmental 

Response, Compensation, and Liability 

Act (‘‘CERCLA’’), 42 U.S.C. 9607, to 

recover its past response costs incurred 

at the Hudson Refinery Superfund Site 

in Cushing, Oklahoma (‘‘Site’’). The 

Consent Decree requires that Defendants 

pay the United States $5.7 million to 

reimburse those past response costs. 

The Consent Decree also resolves 

alleged violations by Defendant Land 

O’Lakes, Inc. of a U.S. Environmental 

Protection Agency CERCLA Unilateral 

Administrative Order at the Site. 

The publication of this notice opens 

a period for public comment on the 

proposed Consent Decree. Comments 

should be addressed to the Assistant 

Attorney General, Environment and 

Natural Resources Division, and should 

refer to United States v. Land O’Lakes, 

Inc., et al., DJ# 90–11–3–11365, Civil 

Case No. 5:16–cv–00170 (W.D. Okla.). 

All comments must be submitted no 

later than thirty (30) days after the 

publication date of this notice. 

Comments may be submitted either by 

email or by mail: 

To submit 

comments: Send them to: 

By email ....... pubcomment-ees.enrd@

usdoj.gov 

By mail ......... Assistant Attorney General, 

U.S. DOJ—ENRD, P.O. 

Box 7611, Washington, DC 

20044–7611. 

During the public comment period, 

the proposed Consent Decree may be 

examined and downloaded at this 

Justice Department website: https://

www.justice.gov/enrd/consent-decrees. 

We will provide a paper copy of the 

proposed amendments upon written 

request and payment of reproduction 

costs. Please mail your request and 

payment to: Consent Decree Library, 

U.S. DOJ—ENRD, P.O. Box 7611, 

Washington, DC 20044–7611. 

Please enclose a check or money order 

for $6.25 (25 cents per page 

reproduction cost) payable to the United 

States Treasury. 

Thomas Carroll, 

Assistant Section Chief, Environmental 

Enforcement Section, Environment and 

Natural Resources Division. 

[FR Doc. 2021–19668 Filed 9–10–21; 8:45 am] 

BILLING CODE 4410–15–P 

DEPARTMENT OF LABOR 

Agency Information Collection 

Activities; Submission for OMB 

Review; Comment Request; American 

Time Use Survey—Eating and Health 

Supplement 

ACTION: Notice of availability; request 

for comments. 

SUMMARY: The Department of Labor 

(DOL) is submitting this Bureau of Labor 

Statistics (BLS)-sponsored information 

collection request (ICR) to the Office of 

Management and Budget (OMB) for 

review and approval in accordance with 

the Paperwork Reduction Act of 1995 

(PRA). Public comments on the ICR are 

invited. 

DATES: The OMB will consider all 

written comments that agency receives 

on or before October 13, 2021. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 


lotter on DSK11XQN23PROD with NOTICES1
50908 Federal Register / Vol. 86, No. 174 / Monday, September 13, 2021 / Notices 

Comments are invited on: (1) Whether 

the collection of information is 

necessary for the proper performance of 

the functions of the Department, 

including whether the information will 

have practical utility; (2) if the 

information will be processed and used 

in a timely manner; (3) the accuracy of 

the agency’s estimates of the burden and 

cost of the collection of information, 

including the validity of the 

methodology and assumptions used; (4) 

ways to enhance the quality, utility and 

clarity of the information collection; and 

(5) ways to minimize the burden of the 

collection of information on those who 

are to respond, including the use of 

automated collection techniques or 

other forms of information technology. 

FOR FURTHER INFORMATION CONTACT: 

Mara Blumenthal by telephone at 202– 

693–8538, or by email at DOL_PRA_

PUBLIC@dol.gov. 

SUPPLEMENTARY INFORMATION: The 

American Time Use Survey (ATUS) is 

the Nation’s first federally administered, 

continuous survey on time use in the 

United States. It measures, for example, 

time spent with children, working, 

sleeping, or doing leisure activities. In 

the United States, several existing 

Federal surveys collect income and 

wage data for individuals and families, 

and analysts often use such measures of 

material prosperity as proxies for 

quality of life. Time-use data 

substantially augment these quality-of 

life measures. The data also can be used 

in conjunction with wage data to 

evaluate the contribution of non-market 

work to national economies. This 

enables comparisons of production 

between nations that have different 

mixes of market and non-market 

activities. For additional substantive 

information about this ICR, see the 

related notice published in the Federal 

Register on July 1, 2021 (86 FR 35138). 

This information collection is subject 

to the PRA. A Federal agency generally 

cannot conduct or sponsor a collection 

of information, and the public is 

generally not required to respond to an 

information collection, unless the OMB 

approves it and displays a currently 

valid OMB Control Number. In addition, 

notwithstanding any other provisions of 

law, no person shall generally be subject 

to penalty for failing to comply with a 

collection of information that does not 

display a valid OMB Control Number. 

See 5 CFR 1320.5(a) and 1320.6. 

DOL seeks PRA authorization for this 

information collection for three (3) 

years. OMB authorization for an ICR 

cannot be for more than three (3) years 

without renewal. The DOL notes that 

information collection requirements 

submitted to the OMB for existing ICRs 

receive a month-to-month extension 

while they undergo review. 

Agency: DOL–BLS. 

Title of Collection: American Time 

Use Survey—Eating and Health 

Supplement. 

OMB Control Number: 1220–0187. 

Affected Public: Individuals or 

Households. 

Total Estimated Number of 

Respondents: 9,435. 

Total Estimated Number of 

Responses: 9,435. 

Total Estimated Annual Time Burden: 

786 hours. 

Total Estimated Annual Other Costs 

Burden: $0. 

Authority: 44 U.S.C. 3507(a)(1)(D). 

Dated: September 3, 2021. 

Mara Blumenthal, 

Senior PRA Analyst. 

[FR Doc. 2021–19635 Filed 9–10–21; 8:45 am] 

BILLING CODE 4510–24–P 

DEPARTMENT OF LABOR 

Agency Information Collection 

Activities; Submission for OMB 

Review; Comment Request; Mental 

Health Parity and Addiction Equity Act 

of 2008 Notices 

ACTION: Notice of availability; request 

for comments. 

SUMMARY: The Department of Labor 

(DOL) is submitting this Employee 

Benefits Security Administration 

(EBSA)-sponsored information 

collection request (ICR) to the Office of 

Management and Budget (OMB) for 

review and approval in accordance with 

the Paperwork Reduction Act of 1995 

(PRA). Public comments on the ICR are 

invited. 

DATES: The OMB will consider all 

written comments that agency receives 

on or before October 13, 2021. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

Comments are invited on: (1) Whether 

the collection of information is 

necessary for the proper performance of 

the functions of the Department, 

including whether the information will 

have practical utility; (2) if the 

information will be processed and used 

in a timely manner; (3) the accuracy of 

the agency’s estimates of the burden and 

cost of the collection of information, 

including the validity of the 

methodology and assumptions used; (4) 

ways to enhance the quality, utility and 

clarity of the information collection; and 

(5) ways to minimize the burden of the 

collection of information on those who 

are to respond, including the use of 

automated collection techniques or 

other forms of information technology. 

FOR FURTHER INFORMATION CONTACT: 

Mara Blumenthal by telephone at 202– 

693–8538, or by email at DOL_PRA_

PUBLIC@dol.gov. 

SUPPLEMENTARY INFORMATION: The 

Departments of Labor, Health and 

Human Services, and the Treasury share 

interpretive jurisdiction of the Mental 

Health Parity and Addiction Equity Act 

(MHPAEA) and have split enforcement 

jurisdictions. The Department of Labor 

is responsible for enforcing MHPAEA 

with respect to private employersponsored group health plans. The 

Consolidated Appropriations Act, 

enacted on December 27, 2020, 

amended MHPAEA, in part, by 

expressly requiring group health plans 

to perform and document a comparative 

analysis of the design and application of 

any non-quantitative treatment 

limitations (NQTLs) that apply to 

medical/surgical and mental health and 

substance use disorder benefits. For 

additional substantive information 

about this ICR, see the related notice 

published in the Federal Register on 

April 22, 2021 (86 FR 21349). 

This information collection is subject 

to the PRA. A Federal agency generally 

cannot conduct or sponsor a collection 

of information, and the public is 

generally not required to respond to an 

information collection, unless the OMB 

approves it and displays a currently 

valid OMB Control Number. In addition, 

notwithstanding any other provisions of 

law, no person shall generally be subject 

to penalty for failing to comply with a 

collection of information that does not 

display a valid OMB Control Number. 

See 5 CFR 1320.5(a) and 1320.6. 

DOL seeks PRA authorization for this 

information collection for three (3) 

years. OMB authorization for an ICR 

cannot be for more than three (3) years 

without renewal. The DOL notes that 

information collection requirements 

submitted to the OMB for existing ICRs 

receive a month-to-month extension 

while they undergo review. 

Agency: DOL–EBSA. 

Title of Collection: Mental Health 

Parity and Addiction Equity Act of 2008 

Notices. 

OMB Control Number: 1210–0138. 

Affected Public: Individuals or 

households; Private Sector—Businesses 


lotter on DSK11XQN23PROD with NOTICES1